| 标题 |
MM-492 Long-term Efficacy and Safety Results From the Phase 1/2 MonumenTAL-1 Study of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lymphoma, Myeloma & Leukemia 作者:L. Rasche; C. Schinke; C. Touzeau; M. Minnema; N. V. van de Donk; et al 出版日期:2024-09-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)